Apple Teams Up with Anthropic to Boost AI Coding Tools

Published 56 minutes agoAAPL

Apple Teams Up with Anthropic to Boost AI Coding Tools

Apple is collaborating with Anthropic, a startup backed by Amazon, to develop a cutting-edge AI-powered coding platform. This initiative aims to create a 'vibe-coding' platform that leverages AI agents to write, edit, and test code, enhancing the capabilities of Apple's current software lineup.

The new platform will specifically integrate with Apple's existing Xcode software, incorporating Anthropic's Claude Sonnet AI model for improved functionality. Reuters reported that initially, Apple plans to deploy this technology internally without any immediate plans for a public release.

This partnership underscores Apple's continued commitment to advancing its AI capabilities. Previously, Apple announced Swift Assist, an AI-driven coding tool for Xcode, which was slated for a 2024 release but was held back due to concerns about possible development delays. Through collaborations like this, Apple aims to strengthen its on-device AI features and broaden its technological offerings.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Liquidia's Stock Jumps 12% After Supreme Court Decision

Liquidia's Stock Jumps 12% After Supreme Court Decision

11 minutes agoLQDA

Liquidia Technologies' stock saw a significant 12% increase, climbing to $11.20, after the U.S. Supreme Court declined to review an appeal concerning the '793 patent of rival United Therapeutics on October 7, 2024. This decision effectively invalidates the patent, eliminating a major hurdle for Liquidia's Yutrepia product, as reported by marketscreener.com. The Supreme Court's move is a breakthrough for Liquidia, which is gearing up for Yutrepia's entry into the market. Yutrepia, approved tentatively by the FDA for treating adults with specific types of pulmonary hypertension, is awaiting final approval, anticipated once a competing product's exclusivity expires in May 2025. In light of the Supreme Court ruling, BTIG analysts have reaffirmed a "Buy" rating for Liquidia with a $25.00 price target, suggesting that the decision plays a crucial role in clearing Yutrepia's path to the market. Liquidia is now better positioned to compete with United Therapeutics' Tyvaso, which currently holds a significant market share. The Supreme Court ruling may expedite Yutrepia's market availability, allowing Liquidia to potentially attract customers from Tyvaso, pushing forward the company's strategic plans for a successful product launch.

CNO Financial Group Boosts Dividend and Share Buyback Program

CNO Financial Group Boosts Dividend and Share Buyback Program

26 minutes agoCNO

CNO Financial Group, Inc. (NYSE: CNO) has announced a 6% increase in its quarterly dividend, pushing the payout to $0.17 per share from the previous $0.16. This marks the company's 13th consecutive annual dividend increase, highlighting its ongoing dedication to shareholder value. The new dividend rate will be payable on June 24, 2025, to those who are recorded as shareholders by June 10, 2025. In addition to the dividend bump, CNO Financial's board has approved an expansion of the share repurchase program by $500 million. This raises the total repurchase capacity to approximately $740.3 million as of December 31, 2024. The move comes ahead of the company's virtual annual meeting, slated for May 8, 2025. These financial maneuvers underscore CNO Financial Group's robust performance and its strategic efforts to enhance shareholder return. As noted by sources such as the company's investor relations page, the annual meeting will offer shareholders the opportunity to engage directly, emphasize corporate governance, and discuss future company endeavors.

Apple Teams Up with Anthropic to Boost AI Coding Tools

Apple Teams Up with Anthropic to Boost AI Coding Tools

56 minutes agoAAPL

Apple is collaborating with Anthropic, a startup backed by Amazon, to develop a cutting-edge AI-powered coding platform. This initiative aims to create a 'vibe-coding' platform that leverages AI agents to write, edit, and test code, enhancing the capabilities of Apple's current software lineup. The new platform will specifically integrate with Apple's existing Xcode software, incorporating Anthropic's Claude Sonnet AI model for improved functionality. Reuters reported that initially, Apple plans to deploy this technology internally without any immediate plans for a public release. This partnership underscores Apple's continued commitment to advancing its AI capabilities. Previously, Apple announced Swift Assist, an AI-driven coding tool for Xcode, which was slated for a 2024 release but was held back due to concerns about possible development delays. Through collaborations like this, Apple aims to strengthen its on-device AI features and broaden its technological offerings.

Foot Locker Earnings Forecast Revised Amidst Mixed Projections

Foot Locker Earnings Forecast Revised Amidst Mixed Projections

Foot Locker, Inc. is gearing up for its first-quarter 2026 earnings announcement, with analysts providing mixed projections. Telsey Advisory Group has adjusted its estimated earnings per share (EPS) for Q1 2026, lowering it to $0.39 from an earlier prediction of $0.46, while maintaining a 'Market Perform' rating and a price target of $24.00. In contrast, Seaport Res Ptn forecasts a significantly lower EPS of ($0.04) for the same period, highlighting divergence among analysts’ expectations. In its fourth-quarter 2024 report, Foot Locker provided guidance for the 52-week period ending January 31, 2026. The company anticipates sales to vary between a 1.0% decrease to a 0.5% increase, factoring in possible foreign currency headwinds of approximately 1.0%. Comparable sales are expected to shift between 1.0% and 2.5%, indicating modest growth or stabilization. Foot Locker's recent financial performance in the fourth quarter of 2024 showed a GAAP EPS of $0.57 from continuing operations and a non-GAAP EPS of $0.86. As of early May 2025, Foot Locker's stock is trading at $13.00, marking a 4.59% increase from the previous closing price, offering some optimism in the market as the company prepares for its upcoming earnings reveal.